These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 32630779)
41. Biocompatible and Antibacterial Nitric Oxide-Releasing Pluronic F-127/Chitosan Hydrogel for Topical Applications. Pelegrino MT; De Araujo Lima B; Do Nascimento MHM; Lombello CB; Brocchi M; Seabra AB Polymers (Basel); 2018 Apr; 10(4):. PubMed ID: 30966487 [TBL] [Abstract][Full Text] [Related]
42. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions. Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476 [TBL] [Abstract][Full Text] [Related]
43. Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release. Seabra AB; da Rocha LL; Eberlin MN; de Oliveira MG J Pharm Sci; 2005 May; 94(5):994-1003. PubMed ID: 15793801 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms. Thomas N; Thorn C; Richter K; Thierry B; Prestidge C J Pharm Sci; 2016 Oct; 105(10):3115-3122. PubMed ID: 27519649 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of superoxide dismutase/H(2)O(2)-mediated nitric oxide release from S-nitrosoglutathione--role of glutamate. Singh RJ; Hogg N; Goss SP; Antholine WE; Kalyanaraman B Arch Biochem Biophys; 1999 Dec; 372(1):8-15. PubMed ID: 10562411 [TBL] [Abstract][Full Text] [Related]
47. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy. Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383 [TBL] [Abstract][Full Text] [Related]
48. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Gordge MP; Hothersall JS; Noronha-Dutra AA Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353 [TBL] [Abstract][Full Text] [Related]
49. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem. Nandakumar V; Geetha V; Chittaranjan S; Doble M Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192 [TBL] [Abstract][Full Text] [Related]
50. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab. Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558 [TBL] [Abstract][Full Text] [Related]
51. Light-regulated nitric oxide release from hydrogel-forming microneedles integrated with graphene oxide for biofilm-infected-wound healing. Ma CJ; He Y; Jin X; Zhang Y; Zhang X; Li Y; Xu M; Liu K; Yao Y; Lu F Biomater Adv; 2022 Mar; 134():112555. PubMed ID: 35523645 [TBL] [Abstract][Full Text] [Related]
53. Influence of Pluronic F127 microenvironments on the photochemical nitric oxide release from S-nitrosoglutathione. Picheth GF; Marini TC; Taladriz-Blanco P; Shimamoto GG; Dos Santos GJVP; Meneau F; de Oliveira MG J Colloid Interface Sci; 2019 May; 544():217-229. PubMed ID: 30849619 [TBL] [Abstract][Full Text] [Related]
54. Catalyzed Nitric Oxide Release Via Cu Nanoparticles Leads to an Increase in Antimicrobial Effects and Hemocompatibility for Short Term Extracorporeal Circulation. Douglass ME; Goudie MJ; Pant J; Singha P; Hopkins S; Devine R; Schmiedt CW; Handa H ACS Appl Bio Mater; 2019 Jun; 2(6):2539-2548. PubMed ID: 33718805 [TBL] [Abstract][Full Text] [Related]
55. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods. Arasoglu T; Derman S; Mansuroglu B Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915 [TBL] [Abstract][Full Text] [Related]
56. Poly Lactic- Xu X; Liu B; Wu H; Zhang Y; Tian X; Tian J; Liu T Nanomaterials (Basel); 2021 Dec; 11(12):. PubMed ID: 34947743 [TBL] [Abstract][Full Text] [Related]
57. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione. Gordge MP; Hothersall JS; Neild GH; Dutra AA Br J Pharmacol; 1996 Oct; 119(3):533-8. PubMed ID: 8894174 [TBL] [Abstract][Full Text] [Related]
58. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055 [TBL] [Abstract][Full Text] [Related]
59. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy. Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320 [TBL] [Abstract][Full Text] [Related]
60. Construction of poly(lactic-co-glycolic acid)/ZnO nanorods/Ag nanoparticles hybrid coating on Ti implants for enhanced antibacterial activity and biocompatibility. Xiang Y; Li J; Liu X; Cui Z; Yang X; Yeung KWK; Pan H; Wu S Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():629-637. PubMed ID: 28629062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]